[Activity Report] Recommendations for Creating a Sustainable Innovation Ecosystem for Antimicrobial R&D (August 1, 2023)
date : 9/13/2023
Tags: AMR
Ahead of next year’s United Nations General Assembly’s High-level Meeting on AMR, representatives from the U.S., Japan, and Canada gathered to explore critical steps that governments and stakeholders can take to help ensure the world has access to the effective antimicrobials and other therapies needed to avert millions of needless deaths and trillions of dollars in added health care expenditures in the future.
The broken marketplace for antimicrobial innovations continues to depress critical investment. While many thought leaders and advocates have been working for decades to jumpstart the R&D pipeline, the panelists agreed the coalition of stakeholders should be broadened to include members of government, the biopharmaceutical industry, medical societies, and think tanks. One avenue to this would be enlisting the help of patients and patient advocates, who can give firsthand accounts to the threat AMR poses to the world.
Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno attended the event.
In addition, the AMR Action Fund and HGPI compiled a document as a thematic summary of the event. The statements do not necessarily represent the views of all participants or organizations.
Please find the document below and read the details here.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)